Literature DB >> 34984921

Developmental alterations of intestinal SGLT1 and GLUT2 induced by early weaning coincides with persistent low-grade metabolic inflammation in female pigs.

Yihang Li1, Kyan M Thelen1, Karina Matos Fernández1, Rahul Nelli1, Mahsa Fardisi1, Mrigendra Rajput1, Nathalie L Trottier2, Genaro A Contreras1, Adam J Moeser1,3.   

Abstract

Early-life adversity (ELA) is linked with the increased risk for inflammatory and metabolic diseases in later life, but the mechanisms remain poorly understood. Intestinal epithelial glucose transporters sodium-glucose-linked transporter 1 (SGLT1) and glucose transporter 2 (GLUT2) are the major route for intestinal glucose uptake but have also received increased attention as modulators of inflammatory and metabolic diseases. Here, we tested the hypothesis that early weaning (EW) in pigs, an established model of ELA, alters the development of epithelial glucose transporters and coincides with elevated markers of metabolic inflammation. The jejunum and ileum of 90-day-old pigs previously exposed to EW (16 days wean age), exhibited reduced SGLT1 activity (by ∼ 30%, P < 0.05) than late weaned (LW, 28 days wean age) controls. In contrast, GLUT2-mediated glucose transport was increased (P = 0.003) in EW pigs than in LW pigs. Reciprocal changes in SGLT1- and GLUT2-mediated transport coincided with transporter protein expression in the intestinal brush-border membranes (BBMs) that were observed at 90 days and 150 days of age. Ileal SGLT1-mediated glucose transport and BBM expression were inhibited by the β-adrenergic receptor (βAR) blocker propranolol in EW and LW pigs. In contrast, propranolol enhanced ileal GLUT2-mediated glucose transport (P = 0.015) and brush-border membrane vesicle (BBMV) abundance (P = 0.035) in LW pigs, but not in EW pigs. Early-weaned pigs exhibited chronically elevated blood glucose and C-reactive protein (CRP) levels, and adipocyte hypertrophy and upregulated adipogenesis-related gene expression in visceral adipose tissue. Altered development of intestinal glucose transporters by EW could underlie the increased risk for later life inflammatory and metabolic diseases.NEW & NOTEWORTHY These studies reveal that early-life adversity in the form of early weaning in pigs causes a developmental shift in intestinal glucose transport from SGLT1 toward GLUT2-mediated transport. Early weaning also induced markers of metabolic inflammation including persistent elevations in blood glucose and the inflammatory marker CRP, along with increased visceral adiposity. Altered intestinal glucose transport might contribute to increased risk for inflammatory and metabolic diseases associated with early-life adversity.

Entities:  

Keywords:  GLUT2; SGLT1; early-life adversity; metabolic disease; porcine intestine

Mesh:

Substances:

Year:  2022        PMID: 34984921      PMCID: PMC9076411          DOI: 10.1152/ajpgi.00207.2021

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  46 in total

1.  Estimating glucose requirements of an activated immune system in growing pigs.

Authors:  S K Kvidera; E A Horst; E J Mayorga; M V Sanz-Fernandez; M Abuajamieh; L H Baumgard
Journal:  J Anim Sci       Date:  2017-11       Impact factor: 3.159

2.  Mechanism of beta-adrenergic agonist-induced transmural transport of glucose in rat small intestine. Regulation of phosphorylation of SGLT1 controls the function.

Authors:  Y Ishikawa; T Eguchi; H Ishida
Journal:  Biochim Biophys Acta       Date:  1997-07-24

3.  Childhood Maltreatment and Psychiatric Comorbidity in Immune-Mediated Inflammatory Disorders.

Authors:  Anthony Wan; Charles N Bernstein; Lesley A Graff; Scott B Patten; Jitender Sareen; John D Fisk; James M Bolton; Carol Hitchon; James J Marriott; Ruth Ann Marrie
Journal:  Psychosom Med       Date:  2022-01-01       Impact factor: 4.312

4.  Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses.

Authors:  J E Medland; C S Pohl; L L Edwards; S Frandsen; K Bagley; Y Li; A J Moeser
Journal:  Neurogastroenterol Motil       Date:  2016-05-02       Impact factor: 3.598

Review 5.  Early-life stress origins of gastrointestinal disease: animal models, intestinal pathophysiology, and translational implications.

Authors:  Calvin S Pohl; Julia E Medland; Adam J Moeser
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-10-08       Impact factor: 4.052

Review 6.  The Link Between Adverse Childhood Experiences and Diabetes.

Authors:  Lindsay Huffhines; Amy Noser; Susana R Patton
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

7.  Expression of nutrient transporters and host defense peptides in Campylobacter challenged broilers.

Authors:  J S Garcia; J A Byrd; E A Wong
Journal:  Poult Sci       Date:  2018-10-01       Impact factor: 3.352

8.  Chronic social stress in pigs impairs intestinal barrier and nutrient transporter function, and alters neuro-immune mediator and receptor expression.

Authors:  Yihang Li; Zehe Song; Katelyn A Kerr; Adam J Moeser
Journal:  PLoS One       Date:  2017-02-07       Impact factor: 3.240

9.  Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.

Authors:  Ian J Neeland; Colby R Ayers; Anand K Rohatgi; Aslan T Turer; Jarett D Berry; Sandeep R Das; Gloria L Vega; Amit Khera; Darren K McGuire; Scott M Grundy; James A de Lemos
Journal:  Obesity (Silver Spring)       Date:  2013-05-19       Impact factor: 5.002

10.  Cumulative early life adversity predicts longevity in wild baboons.

Authors:  Jenny Tung; Elizabeth A Archie; Jeanne Altmann; Susan C Alberts
Journal:  Nat Commun       Date:  2016-04-19       Impact factor: 14.919

View more
  1 in total

Review 1.  Biological sex: an understudied factor driving disease susceptibility in pigs.

Authors:  Adam J Moeser; Andrew Roney; Mahsa Fardisi; Kyan Thelen
Journal:  J Anim Sci       Date:  2022-06-01       Impact factor: 3.338

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.